|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moore MJ: The treatment of advanced
pancreatic cancer: current evidence and future challenges. Ann
Oncol. 19(Suppl 7): vii304–vii308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stathis A and Moore MJ: Advanced
pancreatic carcinoma: current reatment and future challenges. Nat
Rev Clin Oncol. 7:163–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamada S, Masamune A and Shimosegawa T:
Novel therapeutic strategies targeting tumor-stromal interactions
in pancreatic cancer. Front Physiol. 4:3312013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR
and Yang SM: Macrophages in tumor microenvironments and the
progression of tumors. Clin Dev Immunol. 2012:9480982012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Yao Y, Gong C, et al: CCL18 from
tumor-associated macrophages promotes breast cancer metastasis via
PITPNM3. Cancer Cell. 19:541–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mantovani A: The chemokine system:
redundancy for robust outputs. Immunol Today. 20:254–257. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sallusto F and Mackay CR: Chemoattractants
and their receptors in homeostasis and inflammation. Curr Opin
Immunol. 16:724–731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bromley SK, Mempel TR and Luster AD:
Orchestrating the orchestrators: chemokines in control of T cell
traffic. Nat Immunol. 9:970–980. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Strieter RM, Burdick MD, Mestas J,
Gomperts B, Keane MP and Belperio JA: Cancer CXC chemokine networks
and tumour angiogenesis. Eur J Cancer. 42:768–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ijichi H, Chytil A, Gorska AE, et al:
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves
survival in a mouse model of pancreatic ductal adenocarcinoma. J
Clin Invest. 121:4106–4117. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schraufstatter I, Takamori H, Sikora L,
Sriramarao P and DiScipio RG: Eosinophils and monocytes produce
pulmonary and activation-regulated chemokine, which activates
cultured monocytes/macrophages. Am J Physiol Lung Cell Mol Physiol.
286:L494–L501. 2004. View Article : Google Scholar
|
|
14
|
Sallusto F, Palermo B, Lenig D, Miettinen
M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M and
Lanzavecchia A: Distinct patterns and kinetics of chemokine
production regulate dendritic cell function. Eur J Immunol.
29:1617–1625. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pivarcsi A, Gombert M, Dieu-Nosjean MC, et
al: CC chemokine ligand 18, an atopic dermatitis-associated and
dendritic cell-derived chemokine, is regulated by staphylococcal
products and allergen exposure. J Immunol. 173:5810–5817. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schutyser E, Richmond A and Van Damme J:
Involvement of CC chemokine ligand 18 (CCL18) in normal and
pathological processes. J Leukoc Biol. 78:14–26. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schraufstatter IU, Zhao M, Khaldoyanidi SK
and Discipio RG: The chemokine CCL18 causes maturation of cultured
monocytes to macrophages in the M2 spectrum. Immunology.
135:287–298. 2012. View Article : Google Scholar :
|
|
18
|
Zhang B, Yin C, Li H, et al: Nir1 promotes
invasion of breast cancer cells by binding to chemokine (C-C motif)
ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Eur
J Cancer. 49:3900–3913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li D, Duell EJ, Yu K, et al: Pathway
analysis of genome-wide association study data highlights
pancreatic development genes as susceptibility factors for
pancreatic cancer. Carcinogenesis. 33:1384–1390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: International Union Against Cancer (UICC) TNM Classification of
Malignant Tumors. 7th edition. Wiley-Blackwell; Oxford: 2009
|
|
21
|
Ni XG, Bai XF, Mao YL, et al: The clinical
value of serum CEA, CA19-9, and CA242 in the diagnosis and
prognosis of pancreatic cancer. Eur J Surg Oncol. 31:164–169. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yasue M, Sakamoto J, Teramukai S, Morimoto
T, Yasui K, Kuno N, Kurimoto K and Ohashi Y: Prognostic values of
preoperative and postoperative CEA and CA19.9 levels in pancreatic
cancer. Pancreas. 9:735–740. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harris P and Ralph P: Human leukemic
models of myelomonocytic development: a review of the HL-60 and
U937 cell lines. J Leukoc Biol. 37:407–422. 1985.PubMed/NCBI
|
|
24
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The identification of markers of
macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Catusse J, Wollner S, Leick M, Schröttner
P, Schraufstätter I and Burger M: Attenuation of CXCR4 responses by
CCL18 in acute lymphocytic leukemia B cells. J Cell Physiol.
225:792–800. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zissel Gl, Höhne K, Kilic A, Maier C,
Goldmann T, Prasse A, Ploenes T, Trepel M, Eibel H and
Müller-Quernheim J: Identification of the CCL18 receptor - effects
of CCL18 on human lung fibroblasts in pulmonary fibrosis are
mediated via CCR6. Pneumologie. 66:P3_0122012. View Article : Google Scholar
|
|
27
|
Balkwill F, Charles KA and Mantovani A:
Smoldering and polarized inflammation in the initiation and
promotion of malignant disease. Cancer Cell. 7:211–217. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guerra C, Collado M, Navas C, Schuhmacher
AJ, Hernández-Porras I, Cañamero M, Rodriguez-Justo M, Serrano M
and Barbacid M: Pancreatitis-induced inflammation contributes to
pancreatic cancer by inhibiting oncogene-induced senescence. Cancer
Cell. 19:728–739. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Darash-Yahana M, Gillespie JW, Hewitt SM,
et al: The chemokine CXCL16 and its receptor, CXCR6, as markers and
promoters of inflammation-associated cancers. PLoS One.
4:e66952009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schutyser E, Struyf S, Proost P, et al:
Identification of biologically active chemokine isoforms from
ascitic fluid and elevated levels of CCL18/pulmonary and
activation-regulated chemokine in ovarian carcinoma. J Biol Chem.
277:24584–24593. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ploenes T, Scholtes B, Krohn A, Burger M,
Passlick B, Müller-Quernheim J and Zissel G: CC-chemokine ligand 18
induces epithelial to mesenchymal transition in lung cancer A549
cells and elevates the invasive potential. PLoS One. 8:e530682013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Günther C, Zimmermann N, Berndt N, Grosser
M, Stein A, Koch A and Meurer M: Up-regulation of the chemokine
CCL18 by macrophages is a potential immunomodulatory pathway in
cutaneous T-cell lymphoma. Am J Pathol. 179:1434–1442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Plönes T, Krohn A, Burger M, Veelken H,
Passlick B, Müller-Quernheim J and Zissel G: Serum level of
CC-chemokine ligand 18 is increased in patients with non-small-cell
lung cancer and correlates with survival time in adenocarcinomas.
PLoS One. 7:e417462012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Urquidi V, Kim J, Chang M, Dai Y, Rosser
CJ and Goodison S: CCL18 in a multiplex urine-based assay for the
detection of bladder cancer. PLoS One. 7:e377972012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leung SY, Yuen ST, Chu KM, Mathy JA, Li R,
Chan AS, Law S, Wong J, Chen X and So S: Expression profiling
identifies chemokine (C-C motif) ligand 18 as an independent
prognostic indicator in gastric cancer. Gastroenterology.
127:457–469. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fanelli MF, Chinen LT, Begnami MD, Costa
WL Jr, Fregnami JH, Soares FA and Montagnini AL: The influence of
transforming growth factor-α, cyclooxygenase-2, matrix
metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in
epithelial-mesenchymal transition on overall survival of patients
with gastric cancer. Histopathology. 61:153–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hao M, Zheng J, Hou K and Wang J, Chen X,
Lu X, Bo J, Xu C, Shen K and Wang J: Role of chemokine receptor
CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bertran E, Caja L, Navarro E, Sancho P,
Mainez J, Murillo MM, Vinyals A, Fabra A and Fabregat I: Role of
CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that
have undergone epithelial-mesenchymal transition in response to the
transforming growth factor-beta. Cell Signal. 21:1595–606. 2009.
View Article : Google Scholar : PubMed/NCBI
|
